Explore "sglt2 inhibitors" with insightful episodes like "E152 - Therapeutic Guidelines Diabetes", "Episode 99: Smoothing Out the Wrinkles of Migraine" and "Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria" from podcasts like ""Australian Prescriber Podcast", "The EMJ Podcast: Insights For Healthcare Professionals" and "Clinical Journal of the American Society of Nephrology (CJASN)"" and more!
SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.
This week, Jonathan is joined by James Kim, Clinical Assistant Professor, Department of Family Medicine, University of Calgary, Canada. Kim talks about his time studying and working in different continents and the differences in healthcare that struck him during these experiences. Jonathan and Kim also discuss the treatment of chronic migraine using botox and how this compares with the traditional prescription of painkillers, as well as the link between climate change and chronic disease.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io